+

WO2002064626A3 - Proteines humaines secretees isolees, molecules d'acides nucleiques codant pour des proteines humaines secretees et utilisations associees - Google Patents

Proteines humaines secretees isolees, molecules d'acides nucleiques codant pour des proteines humaines secretees et utilisations associees Download PDF

Info

Publication number
WO2002064626A3
WO2002064626A3 PCT/US2001/042802 US0142802W WO02064626A3 WO 2002064626 A3 WO2002064626 A3 WO 2002064626A3 US 0142802 W US0142802 W US 0142802W WO 02064626 A3 WO02064626 A3 WO 02064626A3
Authority
WO
WIPO (PCT)
Prior art keywords
secreted proteins
human secreted
nucleic acid
acid molecules
molecules encoding
Prior art date
Application number
PCT/US2001/042802
Other languages
English (en)
Other versions
WO2002064626A2 (fr
Inventor
Steven I Ladunga
Maureen E Higgins
Eugene Spier
Simon Greenberg
Yu Wang
Original Assignee
Pe Corp Ny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/708,725 external-priority patent/US6489456B1/en
Priority claimed from US09/711,681 external-priority patent/US6503743B1/en
Application filed by Pe Corp Ny filed Critical Pe Corp Ny
Priority to JP2002564955A priority Critical patent/JP2005503117A/ja
Priority to CA002427112A priority patent/CA2427112A1/fr
Priority to EP01273044A priority patent/EP1530586A2/fr
Priority to AU2002258355A priority patent/AU2002258355A1/en
Publication of WO2002064626A2 publication Critical patent/WO2002064626A2/fr
Publication of WO2002064626A3 publication Critical patent/WO2002064626A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'invention concerne des séquences d'acides aminés de peptides codés par des gènes du génome humain, les peptides sécrétés de l'invention. Elle concerne spécifiquement un peptide isolé, des molécules d'acides nucléiques, des procédés d'identification d'orthologues et de paralogues des peptides sécrétés, ainsi que des procédés d'identification de modulateurs des peptides sécrétés.
PCT/US2001/042802 2000-10-27 2001-10-26 Proteines humaines secretees isolees, molecules d'acides nucleiques codant pour des proteines humaines secretees et utilisations associees WO2002064626A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2002564955A JP2005503117A (ja) 2000-10-27 2001-10-26 単離ヒト分泌タンパク質、ヒト分泌タンパク質をコード化する核酸分子、及びそれらの使用
CA002427112A CA2427112A1 (fr) 2000-10-27 2001-10-26 Proteines humaines secretees isolees, molecules d'acides nucleiques codant pour des proteines humaines secretees et utilisations associees
EP01273044A EP1530586A2 (fr) 2000-10-27 2001-10-26 Proteines humaines secretees isolees, molecules d'acides nucleiques codant pour des proteines humaines secretees et utilisations associees
AU2002258355A AU2002258355A1 (en) 2000-10-27 2001-10-26 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof

Applications Claiming Priority (24)

Application Number Priority Date Filing Date Title
US24346700P 2000-10-27 2000-10-27
US24343600P 2000-10-27 2000-10-27
US24342800P 2000-10-27 2000-10-27
US24347600P 2000-10-27 2000-10-27
US24347700P 2000-10-27 2000-10-27
US24342900P 2000-10-27 2000-10-27
US60/243,428 2000-10-27
US60/243,477 2000-10-27
US60/243,476 2000-10-27
US60/243,467 2000-10-27
US60/243,436 2000-10-27
US60/243,429 2000-10-27
US70872300A 2000-11-09 2000-11-09
US70870000A 2000-11-09 2000-11-09
US70872400A 2000-11-09 2000-11-09
US70870100A 2000-11-09 2000-11-09
US09/708,725 US6489456B1 (en) 2000-10-27 2000-11-09 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
US09/711,681 US6503743B1 (en) 2000-10-27 2000-11-09 Isolated nucleic acid encoding a human lactate dehydrogenase and uses thereof
US09/708,700 2000-11-09
US09/708,701 2000-11-09
US09/708,723 2000-11-09
US09/708,724 2000-11-09
US09/708,725 2000-11-09
US09/711,681 2000-11-09

Publications (2)

Publication Number Publication Date
WO2002064626A2 WO2002064626A2 (fr) 2002-08-22
WO2002064626A3 true WO2002064626A3 (fr) 2005-02-10

Family

ID=27583816

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/042802 WO2002064626A2 (fr) 2000-10-27 2001-10-26 Proteines humaines secretees isolees, molecules d'acides nucleiques codant pour des proteines humaines secretees et utilisations associees

Country Status (5)

Country Link
EP (1) EP1530586A2 (fr)
JP (1) JP2005503117A (fr)
AU (1) AU2002258355A1 (fr)
CA (1) CA2427112A1 (fr)
WO (1) WO2002064626A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2190870A4 (fr) * 2007-08-28 2010-12-01 Auckland Uniservices Ltd Marqueur cellulaire d'une lignée de mélanocytes et ses utilisations

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BARTON G J: "PROTEIN SEQUENCE ALIGMENT AND DATABASE SCANNING", PROTEIN STRUCTURE PREDICTION. A PRACTICAL APPROACH, XX, XX, 1996, pages 31 - 63, XP000829540 *
BERGSTEIN I ET AL: "Isolation of two novel WNT genes, WNT14 and WNT15, one of which (WNT15) is closely linked to WNT3 on human chromosome 17q21", GENOMICS, ACADEMIC PRESS, SAN DIEGO, US, vol. 46, no. 3, 15 December 1997 (1997-12-15), pages 450 - 458, XP002110186, ISSN: 0888-7543 *
GEORGE D G ET AL: "CURRENT METHODS IN SEQUENCE COMPARISON AND ANALYSIS", MACROMOLECULAR SEQUENCING AND SYNTHESIS SELECTED METHODS AND APPLICATIONS, XX, XX, 1988, pages 127 - 149, XP000829541 *

Also Published As

Publication number Publication date
AU2002258355A1 (en) 2002-08-28
WO2002064626A2 (fr) 2002-08-22
CA2427112A1 (fr) 2002-08-22
EP1530586A2 (fr) 2005-05-18
JP2005503117A (ja) 2005-02-03

Similar Documents

Publication Publication Date Title
WO2002095049A3 (fr) Proteines isolees secretees par l'humain, molecules d'acides nucleiques codant pour ces proteines secretees par l'humain et leur utilisation
WO2002026947A3 (fr) Proteines proteases humaines isolees, molecules d'acide nucleique codant ces proteines, et utilisation de ces proteines
WO2003006671A3 (fr) Proteines humaines secretees et isolees, molecules d'acide nucleique codant les proteines humaines secretees et utilisation de ces dernieres
WO2002046407A3 (fr) Proteines transporteuses humaines isolees, molecules d'acides nucleiques codant pour les proteines transporteuses humaines et utilisation de ces dernieres
WO2002016566A3 (fr) Proteines proteasiques humaines isolees, molecules d'acides nucleiques codant pour ces proteines proteasiques humaines, et utilisations correspondantes
WO2002079228A3 (fr) Proteines proteasiques humaines isolees, molecules d'acides nucleiques codant pour ces proteines proteasiques humaines et utilisations associees
WO2002050286A3 (fr) Proteines proteases humaines isolees, molecules d'acide nucleique codant ces proteines, et utilisation de ces proteines
WO2003006483A3 (fr) Proteines secretees humaines isolees, molecules d'acide nucleique codantes pour ces proteines secretees humaines et utilisations de celles-ci
WO2003006485A3 (fr) Proteines humaines isolees secretees, molecules d'acides nucleiques codant pour lesdites proteines et utilisations de ces proteines
WO2002077167A3 (fr) Proteines isolees humaines de la protease, molecules d'acide nucleique codant les proteines humaines de la protease et leurs utilisations
WO2002046406A3 (fr) Proteines transporteurs humaines isolees, molecules d'acides nucleiques codant ces proteines, et utilisations correspondantes
WO2003001880A3 (fr) Proteines secretees humaines isolees, molecules d'acide nucleique codant pour ces proteines secretees humaines et utilisations de celles-ci
WO2002083914A3 (fr) Proteines humaines secretees isolees, molecules d'acide nucleique codant des proteines humaines secretees et utilisations associees
WO2002024910A3 (fr) Proteines transporteuses humaines isolees, molecules d'acides nucleiques codant pour ces proteines transporteuses humaines et utilisations
WO2002057310A3 (fr) Proteines de transport humaines isolees, molecules d'acide nucleique codant des proteines de transport humaines et utilisations associees
WO2002024748A3 (fr) Proteines de transport humaines isolees, molecules d'acide nucleique codant ces proteines, et utilisations correspondantes
WO2002020757A3 (fr) Proteines transporteuses humaines isolees, molecules d'acides nucleiques codant pour lesdites molecules transporteuses humaines et utilisations
WO2002046217A3 (fr) Proteines humaines de transport isolees, molecules d'acide nucleique codant pour ces proteines humaines de transport et utilisations desdites proteines
WO2002033086A3 (fr) Proteines transporteuses isolees humaines, molecules d'acide nucleique codant pour ces proteines transporteuses humaines, et leurs utilisations
WO2002064626A3 (fr) Proteines humaines secretees isolees, molecules d'acides nucleiques codant pour des proteines humaines secretees et utilisations associees
WO2002101080A3 (fr) Proteines secretees humaines isolees, molecules d'acide nucleique codant pour ces proteines secretees humaines et utilisations de ces dernieres
WO2002042436A3 (fr) Proteines phosphatases humaines et molecules d'acide nucleique isolees, codant des proteines phosphatases humaines, et leurs utilisations
WO2003006484A3 (fr) Proteines secretees humaines isolees, molecules d'acide nucleique codantes pour ces proteines secretees humaines et utilisations de celles-ci
WO2002079452A3 (fr) Phosphatases humaines isolées, molécules d'acides nucléiques codant ces protéines, et leurs utilisations
WO2002048364A3 (fr) Proteines de transport humaines isolees, molecules d'acide nucleique codant des proteines de transport humaines, et leur utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002564955

Country of ref document: JP

Ref document number: 2427112

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001273044

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2001273044

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 2001273044

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载